Related Experiment Videos
Correlation between cardiovascular disease and diabetes mellitus: current concepts
1Department of Cardiovascular Medicine, Lahey Clinic Medical Center, Burlington, Massachusetts, USA.
The American Journal of Medicine
|March 17, 2004
Summary
Diabetes significantly increases cardiovascular disease (CVD) risk and mortality. Early interventions targeting metabolic defects and risk factors are crucial for improving outcomes in individuals with diabetes and CVD.
Area of Science:
- Cardiology
- Endocrinology
- Metabolic Syndrome
Background:
- Diabetes mellitus and cardiovascular disease (CVD) share common pathogenetic processes.
- Individuals with diabetes, even with precursor symptoms, face elevated CVD mortality risk.
- Cardiovascular risk factors remain undertreated in many patients with diabetes and/or established CVD.
Purpose of the Study:
- To explore the shared pathogenetic mechanisms between diabetes and CVD.
- To highlight the impact of diabetes on endothelial function, atherogenesis, and cardiac function.
- To emphasize the need for early intervention strategies to mitigate cardiovascular risk in diabetic individuals.
Main Methods:
- Review of recent research on the link between diabetes and cardiovascular complications.
- Analysis of metabolic, autonomic, inflammatory, and thrombotic pathways involved.
- Examination of how diabetes affects vascular and myocardial tissue remodeling.
Main Results:
- Core metabolic defects in diabetes (impaired glucose tolerance, insulin resistance) drive endothelial dysfunction and accelerate atherogenesis.
- Increased sympathetic tone in diabetes contributes to hypertension, left ventricular dysfunction, and cardiac autonomic neuropathy.
- Diabetes impairs the ability of cardiac and vascular tissue to remodel and recover after injury.
Conclusions:
- Early implementation of risk factor reduction strategies is vital for individuals with or at risk for diabetes.
- Interventions should include lifestyle modifications (diet, exercise, weight loss) and pharmacologic treatments.
- Addressing hypertension, dyslipidemia, and novel therapeutic targets may improve long-term outcomes and slow diabetes progression.